INDSWFTLAB - Ind-Swift Laboratories

Ind-Swift Laboratories

INDSWFTLAB · Pharma > Pharmaceuticals & Drugs · Chairman: N R Munjal · MD: N R Munjal · Listing date: July 17, 1997 · Employees: 1531 · Chandigarh · http://www.indswiftlabs.com

Stock Price vs Company Growth

6.3%

2.4%

11.7%

23.5%

31.9%

23.4%

31.0%

10y

11.2%

all

3.0%

🤔 How to analyze this graph?

Last Traded Price

₹ 86 6.3%

81.7

119

Company Overview

Sales

447 Cr

Growth: -34.9%

Profit after Tax

-146 Cr

Growth: 15.3%

Small Cap

521 Cr

P/E: 2.1x

Industry P/E: 31.2x

Fundamentals

Sales (Cr)	₹ 447
Growth	-34.9%
EBITDA	-16.4%
P/S	1.2x
Dividend	0.0%
P/E	2.1x
Book Value	₹ 154
PEG Ratio	-0.1x
ROE	-15.7%
P/B	0.6x

Shareholding Pattern

Institutions

Edelweiss India Special Situations Fund Ii

10.43 %

Ec Special Situations Fund

6.82 %

Ashokkumar Chandak

2.79 %

Eisaf Ii Onshore Fund

2.24 %

Sri Ganesh Biotech Private Limited

1.26 %

Promoters

Essix Biosciences Limited

21.71 %

Ind Swift Ltd

16.08 %

N.R. Munjal

1.56 %

Rishav Mehta

0.77 %

Himanshu Jain

0.69 %

Others

Increase Decrease No change

Company Profile Detailed

Ind-Swift Laboratories is a part of the Ind-swift Group and is based at Chandigarh, India. It has been promoted by Ind-Swift Limited in a joint venture with the Punjab State Industrial Development Corporation Limited (PSIDC). The group has established a strong reputation as innovators in the Indian pharmaceutical industry. Ind-Swift Laboratories Ltd. went public in 1997 and concentrated on the manufacturing of Active Pharmaceutical Ingredients (API).

Investors (114)

essix.bi...

conquer....

nrm.port...

Followers (1)

murali5